Clinical Trials Directory

Trials / Terminated

TerminatedNCT03641287

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

The Effects of Moderate Exercise on Distress, Quality of Life, and Biomarkers of Angiogenesis and Chronic Stress in Ovarian Cancer Survivors - A Randomized Controlled Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Many individuals with ovarian cancer experience distress, fatigue, weakness, anxiety, and other symptoms that decrease quality of life. Moderate exercise may improve quality of life, decrease distress, and improve biomarkers associated with prognosis in individuals with ovarian cancer. This clinical trial studies how well moderate exercise works in improving distress, quality of life, and biomarkers of angiogenesis and chronic stress in individuals with ovarian, fallopian tube, and primary peritoneal cancer.

Detailed description

OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (EXERCISE INTERVENTION): Patients meet with exercise physiologist for 1, 60 minute session. Patients then receive individualized exercise prescription with goal of moderate aerobic exercise over 150 minutes per week at home for up to 24 weeks. Patients also receive telephone-based motivational support by exercise physiologist weekly for 24 weeks. ARM II (CONTROL GROUP): Patients maintain habitual levels of physical activity and receive general education material about ovarian cancer and survivorship for 24 weeks. After 24 weeks, patients are offered exercise intervention.

Conditions

Interventions

TypeNameDescription
OTHERExercise CounselingMeet with exercise physiology
OTHERAerobic ExerciseReceive prescription for moderate aerobic exercise
OTHERPhysiological SupportReceive motivational support via telephone care
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
OTHERBest PracticeUndergo habitual level of physical activity

Timeline

Start date
2018-12-05
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2018-08-22
Last updated
2023-11-29
Results posted
2023-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03641287. Inclusion in this directory is not an endorsement.